Q2 2020 Holdings
Filed 2020-08-10 | 60 holdings | $5.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vale SA(VALE) | ADR | 91912E105 | $43.1K | 4,181,600 | 0.8% |
| Charter Communications Inc(CHTR) | Common Stock | 16119P108 | $219.0K | 430 | 4.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | Common Stock | 02043Q107 | $224.0K | 1,513 | 4.2% |
| Argenx SE(ARGX) | ADR | 04016X101 | $436.0K | 1,935 | 8.1% |
| Centene Corp(CNC) | Common Stock | 15135B101 | $472.0K | 7,422 | 8.8% |
| Abbvie Inc(ABBV) | Common Stock | 00287Y109 | $490.0K | 4,990 | 9.1% |
| Ascendis Pharma(ASND) | ADR | 04351P101 | $544.0K | 3,675 | 10.2% |
| Biomarin Pharmaceutical Inc(BMRN) | Common Stock | 09061G101 | $657.0K | 5,326 | 12.3% |
| Beigene LTD(ONC) | ADR | 07725L102 | $1.0M | 5,550 | 19.5% |
| Acadia Pharmaceuticals Inc(ACAD) | Common Stock | 004225108 | $1.1M | 22,847 | 20.7% |